RIG
54
7
URI
45
-4
MCO
78
3
ESS
59
2
GOOG
87
6
NWL
66
-3
BBY
48
2
SLB
42
3
HCA
44
-2
PSA
51
-2
CVS
36
-8
SYK
55
-4
EQIX
63
3
MDLZ
36
2
GOOGL
72
5
BXP
49
-3
EQT
47
8
HRL
50
-3
CNX
76
5
EIX
62
-4
RIG
54
7
URI
45
-4
MCO
78
3
ESS
59
2
GOOG
87
6
NWL
66
-3
BBY
48
2
SLB
42
3
HCA
44
-2
PSA
51
-2
CVS
36
-8
SYK
55
-4
EQIX
63
3
MDLZ
36
2
GOOGL
72
5
BXP
49
-3
EQT
47
8
HRL
50
-3
CNX
76
5
EIX
62
-4
Financhill
Back

CellaVision AB 10K Form

Buy
53

CLVSF
CellaVision AB

Last Price:
25.91
Seasonality Move:
-4.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLVSF News And Ratings

See the #1 stock for the next 7 days that we like better than CLVSF

CLVSF Financial Statistics

Sales & Book Value

Annual Sales: $63.97M
Cash Flow: $2.55M
Price / Cash Flow: 42.07
Annual Sales: $3.19
Price / Book: 8.11

Profitability

EPS (TTM): 0.59730
Net Income (TTM): $14.27M
Gross Margin: $43.74M
Return on Equity: 20.36%
Return on Assets: 15.73%

CellaVision AB Earnings Forecast

Key CellaVision AB Financial Ratios

  • The Gross Profit Margin over the past 17 years for CLVSF is 68.37%.
  • The Selling, General & Administrative Expenses for CLVSF have been equal to 31.40% of Gross Profit Margin.
  • The Research & Development expenses have been 12.30% of Revenue.
  • The Interest Expense is 2.50% of Operating Income.
  • The Net Earning history of CLVSF is 19.24% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 11 years.

CellaVision AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CLVSF
Website: cellavision.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 3.04
Quick Ratio: 2.15

Price-to-Earnings

Trailing P/E Ratio: 50.23
Forward P/E Ratio: 0

CLVSF Technical Analysis vs Fundamental Analysis

Buy
53
CellaVision AB (CLVSF) is a Buy

Is CellaVision AB a Buy or a Sell?

  • CellaVision AB stock is rated a Buy
    The current CellaVision AB [CLVSF] share price is $25.91. The Score for CLVSF is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.